Recently, the German company Elm-Plastic showcased the "Bio-Pipette" at the CPHI (International Pharmaceutical Raw Materials Exhibition) in Frankfurt.
This is an oral pipette made of bioplastic, suitable for the medical and pharmaceutical fields. The pipette has been officially launched and was jointly developed by Elm-Plastic Company, the composite material manufacturer Biovox Company, and its distributor Ultrapolymers.
The selected materials are from Biovox's MedEco series, including polylactic acid (PLA) or 95% biobased polyethylene, all of which have been certified for medical use. These materials possess a variety of excellent properties and comply with the ISO 10993 standard. They can be disinfected through methods such as ethylene oxide (EO) sterilization, radiation sterilization, and SCC sterilization.
The MedEco PLA material developed by Biovox is particularly suitable for injection molding to produce components with stable dimensions and good hand-holding feel. Its hardness and strength enable thin-walled production, thereby reducing material usage; moreover, compared to traditional plastics, this material requires a lower processing temperature, significantly reducing energy consumption.
Compared with traditional polyolefin-based pipettes, the bioplastic pipettes developed by Elm-Plastic Company can reduce 113% of carbon dioxide emissions throughout the "cradle-to-gate" entire life cycle, providing support for the pharmaceutical industry in achieving its sustainable development goals.
